Breaking News Instant updates and real-time market news.

ALXN

Alexion

$112.87

-1.13 (-0.99%)

07:38
01/15/20
01/15
07:38
01/15/20
07:38

Alexion price target raised to $162 from $161 at Raymond James

Raymond James analyst Steven Seedhouse raised his price target for Alexion Pharmaceuticals to $162 and maintained an Outperform rating following the JPM20 conference. In a research note to investors, Seedhouse says Alexion's CEO reiterated that no value would be added if Alexion proactively seeks to sell itself and the company refused to discuss potential interest rumors because :we have better things to do than just address rumors," and that management clarified that after consulting KOLs and regulators and due to the rapidly progressing nature of the disease, the Ultomiris for ALS program was converted from proof of concept to potentially registrational Phase 3 study starting in Q1.

  • 27

    Jan

ALXN Alexion
$112.87

-1.13 (-0.99%)

01/07/20
PIPR
01/07/20
NO CHANGE
Target $180
PIPR
Overweight
Piper 'breathing a sigh of relief' for Alexion, thinks Apellis 'falls short'
Piper Sandler analyst Christopher Raymond believes Apellis' (APLS) PEGASUS study "falls short by a wide margin" of positioning APL-2 as a serious competitor to to Alexion's (ALXN) Soliris in a broad paroxysmal nocturnal hemoglobinuria population and he is "breathing a sigh of relief" with respect to his bullish thesis on the latter's shares. While the headline from the study points to statistical superiority versus Soliris, he sees little to worry about for Alexion's complement franchise and believes the larger question for Apellis remains if Hb change is an approvable endpoint. The PEGASUS trial missed non-inferiority on change in LDH levels, which was the primary endpoint for Alexion's C5 inhibitors, the analyst noted. Raymond, who views today's event as removing a key overhang for Alexion, keeps an Overweight rating on the shares with a $180 price target.
01/07/20
SBSH
01/07/20
NO CHANGE
Target $80
SBSH
Buy
Apellis price target raised to $80 from $37 at Citi
Citi analyst Yigal Nochomovitz believes that APL-2 will take a central role in the treatment of paroxysmal nocturnal hemoglobinuria patients who are poor responders to Alexion's (ALXN) Soliris following the report from Apellis (APLS) of its PEGASUS study top-line results. He is now assuming a 90% probability of approval, up from his prior view of 70%, and now believes that APL-2 can be about a $1B product in PNH. The "muted" stock reaction to the "overwhelmingly positive" data presents a very good buying opportunity, added Nochomovitz, who raised his price target on Apellis shares to $80 from $37.
01/07/20
JPMS
01/07/20
NO CHANGE
JPMS
Overweight
Alexion competitor data 'good,' but impact likely incremental, says JPMorgan
JPMorgan analyst Cory Kasimov said he considers this morning's positive Phase 3 pegcetacoplan data from Apellis (APLS) to be an "incremental negative" for Alexion (ALXN), but even if there's a material loss of share in this setting, it is a small overall segment for Alexion and the impact to his estimates seems "rather modest." While he acknowledges the potential competitive threats to Alexion's paroxysmal nocturnal hemoglobinuria franchise, he also expects continued solid execution on the Soliris-to-Ultomiris conversion, said Kasimov, who has an Overweight rating on Alexion shares.
01/13/20
PIPR
01/13/20
NO CHANGE
Target $180
PIPR
Overweight
Alexion a large cap top pick for 2020, says Piper Sandler
Piper Sandler analyst Christopher Raymond tells investors in a research note that he is incrementally positive on Alexion shares after the company pre-released rough 2019 revenue growth implying sizeable upside to Q419 estimates. More meaningful for the stock, Raymond says, is that management is now guiding to four times more U.S. neurology patients on Soliris/Ultomiris by 2025, which he says equates to roughly $1.2B more than his currently modeled $8.496B total revenue for 2025. Coupled with the company's rapidly progressing pipeline and diversification efforts, Raymond says he remains comfortable with Alexion as a top large cap pick for 2020. The analyst made no change to his Overweight rating or $180 price target.

TODAY'S FREE FLY STORIES

COST

Costco

$313.28

8.6 (2.82%)

18:25
01/21/20
01/21
18:25
01/21/20
18:25
Hot Stocks
Costco CEO: We're a volume company, not a margin company »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 05

    Mar

NFLX

Netflix

$338.24

-1.32 (-0.39%)

18:24
01/21/20
01/21
18:24
01/21/20
18:24
Hot Stocks
Netflix says plans to increase content spending across the board »

Says plans to increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

PBR

Petrobras

$14.76

-0.41 (-2.70%)

18:23
01/21/20
01/21
18:23
01/21/20
18:23
Hot Stocks
Petrobras says CARF issued 'unfavorable' decision on tax proceeding »

Petrobras said that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBI

First Midwest

$21.58

-0.725 (-3.25%)

18:15
01/21/20
01/21
18:15
01/21/20
18:15
Earnings
First Midwest reports Q4 EPS 51c, consensus 50c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

NFLX

Netflix

$338.24

-1.32 (-0.39%)

, DIS

Disney

$143.53

-0.72 (-0.50%)

18:14
01/21/20
01/21
18:14
01/21/20
18:14
Hot Stocks
Netflix says Oscar-nominated original films 'very popular' with users as well »

Netflix (NFLX) says…

NFLX

Netflix

$338.24

-1.32 (-0.39%)

DIS

Disney

$143.53

-0.72 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 04

    Feb

MDT

Medtronic

$120.30

1.32 (1.11%)

18:12
01/21/20
01/21
18:12
01/21/20
18:12
Hot Stocks
Medtronic: Trial shows 'superior' back pain relief with DTM SCS »

Medtronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

NFLX

Netflix

$338.24

-1.32 (-0.39%)

, DIS

Disney

$143.53

-0.72 (-0.50%)

18:07
01/21/20
01/21
18:07
01/21/20
18:07
Hot Stocks
Netflix says seasonality from Q1 to Q2 likely to be 'more balanced' »

Netflix (NFLX) says Q1…

NFLX

Netflix

$338.24

-1.32 (-0.39%)

DIS

Disney

$143.53

-0.72 (-0.50%)

GOOG

Alphabet

$1,484.92

4.64 (0.31%)

GOOGL

Alphabet Class A

$1,482.70

3.58 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 03

    Feb

  • 03

    Feb

  • 04

    Feb

  • 10

    Feb

BFC

Bank First National

$66.28

-0.62 (-0.93%)

18:06
01/21/20
01/21
18:06
01/21/20
18:06
Earnings
Bank First National reports Q4 EPS $1.05, consensus $1.04 »

Net interest margin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$149.01

0.805 (0.54%)

18:01
01/21/20
01/21
18:01
01/21/20
18:01
Periodicals
Spotify's new feature lets influencers post Stories to their playlists, TC says »

Tech Crunch's Sarah…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

HCM

Hutchison China MediTech

$29.56

0.135 (0.46%)

17:58
01/21/20
01/21
17:58
01/21/20
17:58
Syndicate
Hutchison China MediTech files to sell $110M of ADSs »

BofA Securities, Goldman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRG

NRG Energy

$38.52

-0.03 (-0.08%)

17:44
01/21/20
01/21
17:44
01/21/20
17:44
Hot Stocks
NRG Energy raises quarterly dividend to 30c from 3c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

17:34
01/21/20
01/21
17:34
01/21/20
17:34
Hot Stocks
BAE Systems awarded $400.91M Army contract modification »

BAE Systems was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$62.09

-1.31 (-2.07%)

17:32
01/21/20
01/21
17:32
01/21/20
17:32
Earnings
Pinnacle Financial reports Q4 adjusted EPS $1.27, consensus $1.26 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

DGLY

Digital Ally

$0.94

(0.00%)

17:27
01/21/20
01/21
17:27
01/21/20
17:27
Syndicate
Breaking Syndicate news story on Digital Ally »

Digital Ally files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$165.54

-1.03 (-0.62%)

17:24
01/21/20
01/21
17:24
01/21/20
17:24
Downgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AES

AES Corp.

$20.47

-0.02 (-0.10%)

17:23
01/21/20
01/21
17:23
01/21/20
17:23
Hot Stocks
AES Corp's sPower suspends Seneca wind project »

sPower announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTFC

Wintrust Financial

$66.90

-2.03 (-2.95%)

17:20
01/21/20
01/21
17:20
01/21/20
17:20
Earnings
Wintrust Financial reports Q4 EPS $1.44, consensus $1.58 »

For the fourth quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

SKT

Tanger Factory

$15.93

0.56 (3.64%)

, MDR

McDermott

$0.70

(0.00%)

17:18
01/21/20
01/21
17:18
01/21/20
17:18
Hot Stocks
Tanger Factory to replace McDermott in S&P 600 at open on 1/27 »

McDermott International…

SKT

Tanger Factory

$15.93

0.56 (3.64%)

MDR

McDermott

$0.70

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIT

CIT Group

$45.23

-1.17 (-2.52%)

, SKT

Tanger Factory

$15.93

0.56 (3.64%)

17:17
01/21/20
01/21
17:17
01/21/20
17:17
Hot Stocks
Breaking Hot Stocks news story on CIT Group, Tanger Factory »

CIT Group to replace…

CIT

CIT Group

$45.23

-1.17 (-2.52%)

SKT

Tanger Factory

$15.93

0.56 (3.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

IBM

IBM

$139.15

0.84 (0.61%)

17:15
01/21/20
01/21
17:15
01/21/20
17:15
Hot Stocks
IBM says there is continued momentum in hybrid cloud »

Says significant actions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

TKTDY

Takata

$0.00

(0.00%)

, HMC

Honda

$27.60

-0.18 (-0.65%)

17:12
01/21/20
01/21
17:12
01/21/20
17:12
Periodicals
Honda to recall 2.4M older U.S. cars over faulty air bag inflators, Reuters says »

Honda (HMC) said it plans…

TKTDY

Takata

$0.00

(0.00%)

HMC

Honda

$27.60

-0.18 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$59.95

-0.725 (-1.19%)

17:10
01/21/20
01/21
17:10
01/21/20
17:10
Downgrade
Rio Tinto rating change  »

Rio Tinto downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNST

Renasant

$35.37

-0.23 (-0.65%)

17:08
01/21/20
01/21
17:08
01/21/20
17:08
Earnings
Renasant reports Q4 EPS 67c, consensus 66c »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

LYFT

Lyft

$47.91

1.33 (2.86%)

17:07
01/21/20
01/21
17:07
01/21/20
17:07
Hot Stocks
Lyft, LeBron James partner to expand bikeshare access across U.S. »

Lyft announced that it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Feb

AMTD

TD Ameritrade

$50.76

0.25 (0.49%)

, TD

Toronto-Dominion

$56.55

-0.18 (-0.32%)

17:02
01/21/20
01/21
17:02
01/21/20
17:02
Earnings
TD Bank comments on expected impact of TD Ameritrade's Q1 earnings »

TD Bank (TD) announced…

AMTD

TD Ameritrade

$50.76

0.25 (0.49%)

TD

Toronto-Dominion

$56.55

-0.18 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.